Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04812028 · ClinicalTrials.gov registry record · Phase 2
Magnesium Sulfate for Analgesia in Pediatric Transplant
A Phase 2 study, sponsored by University of Minnesota.
- Completed
- Registry status
- Phase 2
- Development phase
- 66
- Enrollment target
NCT04812028 is a Phase 2 study that has completed, run by University of Minnesota. The registered enrollment target is 66 participants.
The verdict
NCT04812028, a Phase 2 study, has completed, sponsored by University of Minnesota.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 66 participants
- Enrollment target
Study Summary
To use magnesium sulfate as adjuvant analgesia by implementing a treatment protocol in order to determine whether can benefit pediatric pain in post-operative transplanted patients and decrease overall opioid consumption.
Interventions
- DRUG Magnesium sulfate
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 66 participants |
| Start Date | 2021-03-01 |
| Est. Completion | 2023-08-10 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04812028
The ClinicalTrials.gov registry entry for NCT04812028 describes a study currently listed as completed, categorized as Phase 2. The registered enrollment target is 66 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Minnesota, which has 966 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Magnesium sulfate is the first listed.
NCT04812028 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT04812028 about?
NCT04812028 is a clinical study titled "Magnesium Sulfate for Analgesia in Pediatric Transplant". To use magnesium sulfate as adjuvant analgesia by implementing a treatment protocol in order to determine whether can benefit pediatric pain in post-operative transplanted patients and decrease overall opioid consumption.
What is the current status of trial NCT04812028?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 66 participants. The study started on 2021-03-01. Estimated completion is 2023-08-10.
What interventions are being tested in trial NCT04812028?
The interventions under investigation include: Magnesium sulfate (DRUG).
Who is sponsoring clinical trial NCT04812028?
This trial is sponsored by University of Minnesota, which has 966 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.